Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Depreciation & Amortization (CF) (2010 - 2026)

Analysis

Cerenome (CNSY) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn -
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn -
5 Revolution Medicines 44.41 Bn 44.41 Bn - -
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn 40.52 Mn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn -
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn -
10 Cerenome 20.42 Mn 11.83 Mn - 137,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 137,000.00
Mar 31, 2026 96,000.00
Dec 31, 2025 145,000.00
Sep 30, 2025 77,000.00
Jun 30, 2025 77,000.00
Mar 31, 2025 146,000.00
Dec 31, 2024 348,000.00
Sep 30, 2024 199,000.00
Jun 30, 2024 170,000.00
Mar 31, 2024 155,000.00
Dec 31, 2023 151,000.00
Sep 30, 2023 159,000.00
Jun 30, 2023 160,000.00
Mar 31, 2023 158,000.00
Dec 31, 2022 159,000.00
Sep 30, 2022 158,000.00
Jun 30, 2022 155,000.00
Mar 31, 2022 147,000.00
Dec 31, 2021 129,000.00
Sep 30, 2021 87,000.00